ACADIA Pharmaceuticals Inc (NAS:ACAD)
$ 16.95 -0.42 (-2.42%) Market Cap: 2.89 Bil Enterprise Value: 2.37 Bil PE Ratio: 22.27 PB Ratio: 5.01 GF Score: 75/100

ACADIA Pharmaceuticals Inc at Bank of America Global Research Healthcare Conference (Virtual) Transcript

May 12, 2021 / 06:45PM GMT
Release Date Price: $21.83 (+4.75%)
Tazeen Ahmad
BofA Securities, Research Division - VP

Hi, everybody. Good afternoon, and thanks for continuing to join us at the Bank of America Healthcare conference. It's my pleasure to have with me for the next 30 minutes several members of the management team from Acadia Pharmaceuticals. Steve Davis, Serge Stankovic and Elena Ridloff. Good afternoon. Thanks for joining.

Stephen R. Davis
ACADIA Pharmaceuticals Inc. - CEO & Director

Thanks, Tazeen.

Tazeen Ahmad;Stephen R. Davis
BofA Securities, Research Division - VP;ACADIA Pharmaceuticals

So we're meeting virtually this year again. We hope to be back in Vegas, but we'll try to make the best of the time that we have together. I thought that it would be good for everybody to get an overview of what is going on at ACADIA. There might be some folks on this webcast that aren't as familiar with the story. So usually, I'd like to ask for a quick 2-minute pitch and Steve, I'm going to ask you to pitch ACADIA for 2 minutes or less.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot